CN118871117A - 水杨酸组合物及其用途 - Google Patents

水杨酸组合物及其用途 Download PDF

Info

Publication number
CN118871117A
CN118871117A CN202380022425.XA CN202380022425A CN118871117A CN 118871117 A CN118871117 A CN 118871117A CN 202380022425 A CN202380022425 A CN 202380022425A CN 118871117 A CN118871117 A CN 118871117A
Authority
CN
China
Prior art keywords
extract
metabolite
salicylic acid
formulation
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380022425.XA
Other languages
English (en)
Chinese (zh)
Inventor
菲利普·穆维里
奥利维耶·波特拉特
布鲁诺·施奈德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmalp Corp
Universitaet Basel
Original Assignee
Pharmalp Corp
Universitaet Basel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmalp Corp, Universitaet Basel filed Critical Pharmalp Corp
Publication of CN118871117A publication Critical patent/CN118871117A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202380022425.XA 2022-02-22 2023-02-22 水杨酸组合物及其用途 Pending CN118871117A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158048 2022-02-22
EP22158048.3 2022-02-22
PCT/EP2023/054364 WO2023161247A1 (en) 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof

Publications (1)

Publication Number Publication Date
CN118871117A true CN118871117A (zh) 2024-10-29

Family

ID=80447273

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380022425.XA Pending CN118871117A (zh) 2022-02-22 2023-02-22 水杨酸组合物及其用途

Country Status (8)

Country Link
US (1) US20250152609A1 (https=)
EP (1) EP4482580A1 (https=)
JP (1) JP2025506335A (https=)
CN (1) CN118871117A (https=)
AU (1) AU2023224336A1 (https=)
CA (1) CA3261158A1 (https=)
MX (1) MX2024009823A (https=)
WO (1) WO2023161247A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123356B2 (en) * 2017-03-09 2021-09-21 Epilobium, Inc. Methods of use for oenothein A and B from Epilobium species
US11400102B2 (en) * 2019-05-23 2022-08-02 Washington University Treatment for bacterial infections with salicylic acid analogs

Also Published As

Publication number Publication date
CA3261158A1 (en) 2023-08-31
AU2023224336A1 (en) 2024-07-25
US20250152609A1 (en) 2025-05-15
EP4482580A1 (en) 2025-01-01
MX2024009823A (es) 2024-08-20
JP2025506335A (ja) 2025-03-11
WO2023161247A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
AU2011315708B2 (en) Formulations for the treatment of disorders of the upper respiratory tract
JP6226459B2 (ja) Ｆｒａｘｉｎｕｓｅｘｃｅｌｓｉｏｒ種子の抽出物とその治療適用
Du et al. Gastroprotective effect of eupatilin, a polymethoxyflavone from Artemisia argyi H. Lév. & Vaniot, in ethanol-induced gastric mucosal injury via NF-κB signaling pathway
Jin et al. EtOAc extract of H. attenuatum Choisy inhibits inflammation by suppressing the NF-κB and MAPK pathways and modulating the gut microbiota
US20190038595A1 (en) Cranberry Extract Useful in the Treatment and Prevention of Urinary Infections
US6979471B1 (en) Composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from Glycyrrhiza glabra
EP3134099B1 (en) Anti-candida compositions and uses thereof
KR102036339B1 (ko) 느릅나무껍질, 익모초 및 청미래덩굴 뿌리 추출물을 포함하는 항균 및 항진균용 조성물 및 이를 포함하는 질염 예방 또는 치료용 약학적 조성물, 및 여성청결제용 조성물
Chen et al. Inhibition of porcine origin Klebsiella pneumoniae capsular polysaccharide and immune escape by BY3 compounded traditional Chinese medicine residue fermentation broth
EP3558459A1 (en) Composition for use in the treatment of disorders of the urogenital apparatus
US20240269219A1 (en) Pharmaceutical composition and its antiviral use
CN110300593B (zh) 用于咳嗽的组合物
CN118871117A (zh) 水杨酸组合物及其用途
Rao et al. Isolation and characterization of a potent antimicrobial compound from Aerva sanguinolenta Blume: An alternative source of bakuchiol
CN103889430B (zh) 一种金银花提取物、包含其的药物组合物及其用途
Tchoumba Tchoumi et al. Antimicrobial and antidiarrhoeal activities of aqueous and methanolic extracts of Mangifera indica Linn stem bark (Anarcadiaceae) in Wistar rats: LMT Tchoumi et al.
CN112516232A (zh) 抗菌、抗炎、抗氧化的乌拉草提取物及制备方法和应用
Mira et al. Antiparasitic and antimicrobial activity of Ipomoea palmata against Toxoplasma gondii and Staphylococcus aureus: correlation with major phenolics identified by HPLC
CN103889431B (zh) 开联番木鳖苷酸、包含其的药物组合物及其用途
Valdi et al. Investigating the Antibacterial, Antioxidant, and Anti‐Inflammatory Activities of Aqueous and Hydroethanolic Extracts of Ocimum basilicum and Ocimum gratissimum on Some Germs Responsible for Aerobic Vaginitis
CN111840340A (zh) 石榴皮鞣质在制备抑制细菌群体感应系统药物中的应用
JP2004083581A (ja) 尿路感染症の治療剤
US20110201568A1 (en) Phyotochemical composition and a process thereof
WO2002017939A1 (en) A composition comprising pharmaceutical/nutraceutical agent and a bio-enhancer obtained from glycyrrhiza glabra
Phan et al. Investigation of the antitussive activity of Phyllanthus amarus extract on in vitro and in vivo models

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination